HTG MOLECULAR DIAGNOSTICS IN - COM (HTGM) Institutional Ownership

CUSIP: 40434H104

13F Institutional Holders and Ownership History from Q2 2015 to Q2 2021

Type / Class
Equity / COM
Symbol
HTGM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 40434H104?
CUSIP 40434H104 identifies HTGM - HTG MOLECULAR DIAGNOSTICS IN - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of HTG MOLECULAR DIAGNOSTICS IN - COM (HTGM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q2 0 $0 -$3,000 0
2021 Q1 466 $3,000 $6.44 1
2020 Q4 466 $2,000 -$5,147,043 $4.29 1
2020 Q3 15,506,874 $5,121,000 -$403,471 $0.33 23
2020 Q2 13,755,353 $9,904,000 +$52,851 $0.72 24
2020 Q1 17,802,687 $5,784,000 -$465,981 $0.32 28
2019 Q4 18,975,001 $13,320,000 -$2,376,019 $0.70 25
2019 Q3 22,399,256 $14,978,000 +$4,656,573 $0.67 42
2019 Q2 12,939,647 $21,481,000 -$111,587 $1.66 42
2019 Q1 12,943,280 $32,368,000 -$3,849,708 $2.50 39
2018 Q4 14,564,952 $36,985,000 -$2,751,738 $2.54 48
2018 Q3 13,267,532 $66,965,000 -$2,427,351 $5.05 54
2018 Q2 13,973,024 $45,560,000 +$8,859,612 $3.26 43
2018 Q1 11,180,901 $40,471,670 +$33,092,933 $3.62 39
2017 Q4 2,057,772 $4,174,105 +$476,661 $2.03 17
2017 Q3 1,893,591 $3,218,350 -$2,313,892 $1.70 21
2017 Q2 2,479,115 $6,593,310 -$1,754,422 $2.66 17
2017 Q1 2,983,120 $20,643,220 +$673,643 $6.92 20
2016 Q4 2,887,834 $6,469,840 -$1,022,225 $2.24 12
2016 Q3 3,338,184 $7,652,945 -$154,822 $2.27 21
2016 Q2 3,401,108 $9,065,520 -$279,403 $2.71 22
2016 Q1 3,501,284 $10,048,185 -$657,092 $2.87 19
2015 Q4 3,679,934 $16,043,000 -$385,236 $4.36 19
2015 Q3 3,731,369 $28,435,000 -$227,047 $7.62 20
2015 Q2 3,695,159 $41,202,000 +$41,202,000 $11.15 22